サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1529384

コンパートメント症候群治療の世界市場-2024-2031

Global Compartment Syndrome Treatment Market - 2024-2031

出版日
ページ情報
英文 181 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
コンパートメント症候群治療の世界市場-2024-2031
出版日: 2024年08月06日
発行: DataM Intelligence
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

世界のコンパートメント症候群治療市場は、2023年に3億1,680万米ドルに達し、2024-2031年の予測期間中にCAGR 6.3％で成長し、2031年には5億1,660万米ドルに達すると予測されています。

コンパートメント症候群は、筋肉内の圧力が危険なレベルまで高まると起こる痛みを伴う症状です。この圧力によって血流が減少し、神経細胞や筋肉細胞に栄養や酸素が行き届かなくなります。コンパートメント症候群には、急性（短期間に激しい症状が出る）と慢性（長期間続く）があります。

急性コンパートメント症候群は外科的緊急疾患です。手術以外の有効な治療はありません。切開して患部の皮膚と筋膜を切開します。この処置は筋膜切開術と呼ばれます。

慢性コンパートメント症候群は非外科的治療です。理学療法、装具（靴の中敷き）、および抗炎症薬は、症状の緩和において限られた効果しか期待できず、一般的に完全な活動への復帰は不可能です。

コンパートメント症候群の治療に使用される薬剤には、オピオイド、非オピオイド、NSAIDsがあります。市場は、外傷性傷害の発生率の増加や治療技術の進歩といった要因によって牽引されています。

市場力学：

促進要因

外傷の発生率の増加

世界のコンパートメント症候群治療市場の需要は、複数の要因によって牽引されています。外傷性傷害の発生率の増加は、市場の成長を促進すると予想されます。交通事故、スポーツ傷害、戦闘傷害などの外傷は、コンパートメント症候群の主な原因です。

急性コンパートメント症候群（ACS）は、特に長骨骨折を伴う重大な外傷の直後に発症することが最も多いです。2023年1月のMedscapeニュースによると、外傷ICU入院における腹部コンパートメント症候群の頻度は5～15％で、一般外傷入院の1％です。

さらに、この業界の主要企業が現在進行中の調査研究が、この市場の成長を促進すると思われます。2024年3月のNCBIの調査発表によると、2015年から2022年の間に、外傷性コンパートメント症候群の症例は合計13,305例でした。このうち61％が下肢、11％が上肢に発症しました。症例のかなりの部分（25.2％）は、正確な部位分類を欠いていました。外傷性コンパートメント症候群の多くは男性に発症した（女性4092例対男性9213例）。

同様に、2023年12月のEFFORTオープンレビューによると、脛骨骨折におけるACSは受傷部位によって異なり、脛骨プラトー骨折では12％前後、高エネルギーパターンでは53％に達します。

抑制要因

治療費の高さ、限られた治療オプションしか利用できないこと、個人の認知度や診断が限られていることなどが、市場の妨げになると予想されます。

本レポートの詳細について- サンプル請求

目次

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 外傷性傷害の発生率の増加
      • 治療技術の進歩
    • 抑制要因
      • 治療費の高騰
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 治療タイプ別

  • 筋膜切開術
  • 装具
  • 医薬品
    • オピオイド
    • 非オピオイド
    • 非ステロイド性抗炎症薬

第7章 症候群タイプ別

  • 急性コンパートメント症候群
  • 慢性コンパートメント症候群

第8章 エンドユーザー別

  • 病院およびクリニック
  • 外来手術センター
  • その他

第9章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第10章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第11章 企業プロファイル

  • Stryker
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • BD
  • C2DX, Inc
  • Accuryn Medical
  • Medline Industries, LP.
  • MY01
  • Convatec Inc
  • RAUMEDIC AG
  • Millar, LLC
  • Mirador Biomedical

第12章 付録

目次
Product Code: PH8567

Overview

The global compartment syndrome treatment market reached US$ 316.8 million in 2023 and is expected to reach US$ 516.6 million by 2031 growing with a CAGR of 6.3% during the forecast period 2024-2031.

Compartment syndrome is a painful condition that occurs when pressure within the muscles builds to dangerous levels. This pressure can decrease blood flow, which prevents nourishment and oxygen from reaching nerve and muscle cells. Compartment syndrome can be either acute (having severe symptoms for a short period) or chronic (long-lasting).

Acute compartment syndrome is a surgical emergency. There is no effective nonsurgical treatment. An incision and cut open the skin and fascia covering the affected compartment. This procedure is called a fasciotomy.

Chronic compartment syndrome is a nonsurgical treatment. Physical therapy, orthotics (inserts for shoes), and anti-inflammatory medicines may be of limited benefit in relieving symptoms and generally do not allow a return to full activity.

Drugs used for comportment syndrome treatment involve opioids, non-opioids, and NSAIDs. The market is driven by factors such as the increasing incidence of traumatic injuries and technological advancements in treatment.

Market Dynamics: Drivers

Increasing incidence of traumatic injuries

The demand for the global compartment syndrome treatment market is driven by multiple factors. The increasing incidence of traumatic injuries is expected to drive the growth of the market. Traumatic injuries, such as road accidents, sports injuries, and combat injuries, are major causes of compartment syndrome.

Acute compartment syndrome (ACS) most often develops soon after significant trauma, particularly involving long bone fractures. According to Medscape news in January 2023, the frequency of abdominal compartment syndrome in trauma ICU admissions is anywhere from 5 to 15% and 1% of general trauma admissions.

Moreover, major players in the industry's ongoing research studies would propel this market growth. According to an NCBI research publication in March 2024, during the period from 2015 to 2022, a total of 13,305 cases of traumatic compartment syndromes. Of these, 61% manifested in the lower extremities and 11% in the upper extremities. A significant portion of cases lacked precise localization classification (25.2%). Most traumatic compartment syndromes occurred in males (4092 cases in females vs. 9213 in males).

Similarly, as per EFFORT open reviews in December 2023, ACS in tibial fractures varies depending on the injury site, around 12% for tibial plateau fractures, reaching up to 53% in higher-energy patterns.

Restraints

Factors such as the high cost of treatment, the availability of limited treatment options, and limited awareness & diagnosis among individuals, are expected to hamper the market.

For more details on this report - Request for Sample

Segment Analysis

The global compartment syndrome treatment market is segmented based on treatment type, syndrome type, end-users, and region.

The fasciotomy segment accounted for approximately 51.3% of the global compartment syndrome treatment market share

The fasciotomy segment is expected to hold the largest market share over the forecast period. Fascia are the thick sheets of connective tissue that surround muscle compartments. Fasciotomy, a procedure in which the fascia is cut to relieve pressure in the muscle compartment, is used to treat people with acute or chronic compartment syndrome.

A fasciotomy consists of 1 or more fascial incisions and remains the only effective way to treat acute compartment syndrome. Fasciotomy is a surgical procedure that involves making an incision in the skin and underlying tissue to relieve pressure on the affected nerve or muscle. According to Healio news in April 2024, Atraumatic idiopathic compartment syndrome requiring emergent fasciotomy.

Moreover, key players in the market technological advancements in fasciotomy drive the market growth. The development of advanced intracompartmental pressure monitoring devices enhances the accuracy and reliability of diagnosing compartment syndrome, guiding surgeons in determining the necessity and timing of fasciotomy.

As per NCBI publication in March 2024, an FDA-approved device was used for continuous compartment pressure monitoring. The sensor tip is placed in the muscle belly, and the trochar is then detached from the sensor, allowing the sensor to remain in place. Innovations in imaging technologies, such as portable ultrasound devices, aid in pre-operative planning and intraoperative assessment during fasciotomy procedures.

Geographical Analysis

North America accounted for approximately 43.8% of the global compartment syndrome treatment market share.

North America region is expected to hold the largest market share over the forecast period owing to the high incidence of trauma and sports-related injuries as per NCBI April 2024, the incidence of ACS is estimated to be 7.3 per 100,000 in males and 0.7 per 100,000 in females.

According to the National Safety Council in 2023, 3.7 million people were treated in emergency departments for injuries involving sports and recreational equipment. The activities most frequently associated with injuries are exercise, cycling, and basketball. Amongst American children and adolescents, sports and recreational activities contribute to the growth of the market.

Moreover, key player's innovative initiatives, growing awareness of the syndrome, advancements in medical technology, and increased focus on sports medicine propel this market growth in this region. For instance, in August 2023, Sentinel Medical Technologies addressed the IAP transducer shortage with the trauma ward. IAP monitoring is a critical component of patient care in OR and ICU settings. It serves as a crucial guide for medical teams in assessing the risk of developing Intra-Abdominal Hypertension (IAH) and Abdominal Compartment Syndrome (ACS), conditions that can have severe consequences if not addressed promptly.

Market Segmentation

By Treatment Type

  • Fasciotomy
  • Orthotics
  • Drugs
    • Opioids
    • Non-Opioids
    • NSAIDs

By Syndrome Type

  • Acute Compartment Syndrome
  • Chronic Compartment Syndrome

By End-User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • The rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the compartment syndrome treatment market include Stryker, BD, C2DX, Inc., Accuryn Medical, Medline Industries, LP., MY01, Convatec Inc., RAUMEDIC AG, Millar, LLC, and Mirador Biomedical among others.

Key Developments

  • In May 2021, MY01 Inc. received FDA clearance for the MY01 continuous compartment pressure monitor as an aid in the diagnosis of compartment syndrome.

Why Purchase the Report?

  • To visualize the global compartment syndrome treatment market segmentation based on treatment type, syndrome type, end-users, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the compartment syndrome treatment market with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping is available in Excel consisting of key products of all the major players.

The global compartment syndrome treatment market report would provide approximately 62 tables, 58 figures, and 181 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Treatment Type
  • 3.2. Snippet by Syndrome Type
  • 3.3. Snippet by End-Users
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Incidence of Traumatic Injuries
      • 4.1.1.2. Technological Advancements in Treatment
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Treatment
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Treatment Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 6.1.2. Market Attractiveness Index, By Treatment Type
  • 6.2. Fasciotomy *
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Orthotics
  • 6.4. Drugs
    • 6.4.1. Opioids
    • 6.4.2. Non-Opioids
    • 6.4.3. NSAIDs

7. By Syndrome Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Syndrome Type Market Attractiveness Index, By Syndrome Type
  • 7.2. Acute Compartment Syndrome*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Chronic Compartment Syndrome

8. By End-Users

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
    • 8.1.2. Market Attractiveness Index, By End-Users
  • 8.2. Hospitals & Clinics *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Syndrome Type
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Syndrome Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Syndrome Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Syndrome Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Syndrome Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Stryker *
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. BD
  • 11.3. C2DX, Inc
  • 11.4. Accuryn Medical
  • 11.5. Medline Industries, LP.
  • 11.6. MY01
  • 11.7. Convatec Inc
  • 11.8. RAUMEDIC AG
  • 11.9. Millar, LLC
  • 11.10. Mirador Biomedical

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us